3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Pancreatic Neoplasms
3
Duodenal Neoplasms
2
Pancreatitis, Chronic
1
Neoplasms
1
Cholangiocarcinoma
1
Biliary Tract Neoplasms
1
Bile Duct Neoplasms
1
Interventions
Gemcitabine
18
Cisplatin
13
Oxaliplatin
8
Capecitabine
7
Leucovorin
6
Fluorouracil
5
pembrolizumab
4
Photochemotherapy
3
Irinotecan
3
ivosidenib
2
Cholangiopancreatography, Endoscopic Retrograde
2
zanidatamab
1
toripalimab
1
pemigatinib
1
lenvatinib
1
infigratinib
1
durvalumab
1
cemiplimab
1
becatecarin
1
atezolizumab
1
Tissue Adhesives
1
Tegafur
1
Taxes
1
S 1 (combination)
1
Radiotherapy, Image-Guided
1
Radiation
1
Platinum
1
Pancreaticojejunostomy
1
Nivolumab
1
Neoadjuvant Therapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Cholangiocarcinoma
×
Pancreaticojejunostomy
×
Clear all
NCT07155525
2025-09-18
NBCA-MS
Minia University
Phase 3
Recruiting
194 enrolled